Europe
Clinical News
Informatics
Industry News
Practice Management
Education
Subspecialties
More
Sign In
Installations
Product News
Regulatory
M&A
Market Analysis
Regulatory: Page 9
Stryker nets FDA clearance for Q Guidance
By
AuntMinnie.com staff writers
Orthopedic device developer Stryker has garnered U.S. Food and Drug Administration (FDA) 510(k) clearance for its Q Guidance spine surgery navigation software.
May 30, 2022
Telix gets pass-through status for Illuccix
By
AuntMinnie.com staff writers
Telix Pharmaceuticals has received transitional pass-through payment status from the U.S. Centers for Medicare and Medicaid Services for its Illuccix prostate-specific membrane antigen PET radiopharmaceutical.
May 30, 2022
FDA urges risk management plans for drug shortages
By
AuntMinnie.com staff writers
The U.S. Food and Drug Administration (FDA) is calling on drug manufacturers to develop risk management plans to handle drug shortages.
May 19, 2022
ACR hails request to hold surprise billing appeal
By
AuntMinnie.com staff writers
The American College of Radiology (ACR) and two other medical associations are pleased with the U.S. government’s decision to “hold” on its appeal of a federal court ruling in Texas on the interim final rule (IFR) for the No Surprises Act.
May 5, 2022
FDA grants approval for diagnostic test for Alzheimer's plaques
By
AuntMinnie.com staff writers
The U.S. Food and Drug Administration (FDA) has granted clearance for an vitro diagnostic test that could compete with PET for assessing whether individuals have amyloid plaque buildup associated with Alzheimer's disease.
May 5, 2022
AUC penalty phase set to begin
By
Sandy Coffta
Will the U.S. government's requirement to use clinical decision support (CDS) to order advanced imaging scans finally become a reality? Sandy Coffta of Healthcare Administrative Partners ponders this question.
May 5, 2022
Franklin Mountain gets FDA nod for dual-lumen catheter
By
AuntMinnie.com staff writers
Interventional cardiology technology developer Franklin Mountain Medical has secured U.S. Food and Drug Administration (FDA) clearance for its UltraNav transseptal dual-lumen catheter.
April 25, 2022
Provider relief fund reporting extensions are available
By
Rebecca Farrington
Is your radiology practice looking for an extension on the reporting requirements involved in receiving grants under the U.S. government's Provider Relief Funds program? If so, Rebecca Farrington of Healthcare Administrative Partners offers some guidance.
April 25, 2022
FDA patient committee to discuss virtual reality technology
By
AuntMinnie.com staff writers
A committee of the U.S. Food and Drug Administration (FDA) that represents the interests of patients plans to meet in July to discuss medical devices that use augmented reality and virtual reality.
April 12, 2022
FDA says AI doesn't exclude LVO cases from radiologist review
By
Brian Casey
Artificial intelligence (AI) software shouldn't be used to rule out cases of intracranial large-vessel occlusion (LVO) from radiologist review, according to an advisory issued April 11 by the U.S. Food and Drug Administration.
April 10, 2022
CMS criticized for final decision on Aduhelm reimbursement
By
Will Morton
The U.S. Centers for Medicare and Medicaid Services (CMS) finalized a plan April 7 that limits coverage of Biogen's Alzheimer's disease drug Aduhelm only to patients enrolled in clinical trials, despite pressure from the Society of Nuclear Medicine and Molecular Imaging and other groups to expand coverage of the drug.
April 7, 2022
CMS finalizes rule on limited payment for Alzheimer's drugs
By
AuntMinnie.com staff writers
The U.S. Centers for Medicare and Medicaid Services (CMS) has issued a final national coverage determination that limits coverage for Alzheimer's monoclonal antibody drugs like aducanumab only to people enrolled in qualifying clinical trials.
April 6, 2022
Previous Page
Page 9 of 302
Next Page